Nano Precision Medical, now part of Vivani Medical, is a clinical-stage developer of therapeutic implants. Operating under the Biopharm Division and Neuromodulation Division of Vivani, they aim to maximize the benefit and minimize the burden of treatment for patients with chronic conditions. Their lead product candidate, NPM-119, is a miniature subdermal implant designed to provide steady therapeutic exposure of exenatide for at least six months.

This implant candidate has the potential to revolutionize the treatment of patients with type 2 diabetes by assuring medication adherence and freeing them from the hassles of daily pills or weekly injections. Nano Precision Medical leverages their NanoPortal platform to develop drug implant candidates that deliver molecules steadily over months. Their goal is to improve patient outcomes by providing better medical solutions.

With their innovative approach, Nano Precision Medical is set to transform healthcare. For more information, visit Vivani. com